Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?
Open accessThe DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
Chronic rhinosinusitis (CRS) has recently undergone a significant paradigm shift, moving from a phenotypical classification towards an “endotype-based” definition that places more emphasis on clinical and therapeutic aspects. Similar to other airway diseases, like asthma, most cases of CRS in developed countries exhibit a dysregulated type-2 immune response and related cytokines. Consequently, the traditional distinction between upper and lower airways has been replaced by a “united airway” perspective. Additionally, type-2 related disorders extend beyond respiratory boundaries, encompassing conditions beyond the airways, such as atopic dermatitis. This necessitates a multidisciplinary approach. Moreover, consideration of possible systemic implications is crucial, particularly in relation to sleep-related breathing diseases like Obstructive Sleep Apnoea Syndrome (OSAS) and the alteration of systemic inflammatory mediators such as nitric oxide. The trends in epidemiological, economic, and social burden are progressively increasing worldwide, indicating syndemic characteristics. In light of these insights, this narrative review aims to present the latest evidence on respiratory type-2 related disorders, with a specific focus on CRS while promoting a comprehensive perspective on the “united airways”. It also introduces a novel concept: viewing these conditions as a multiorgan, systemic, and syndemic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“diseases are not evenly dispersed across populations but rather tend to cluster in disadvantaged groups that suffer elevated rates of multimorbidity”
From Is Pollution the Primary Driver of Infectious Syndemics? (2024) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“such clustering increases opportunities for disease interactions across various biological and psychological pathways”
From Is Pollution the Primary Driver of Infectious Syndemics? (2024) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The TSLP alarmin produced by keratinocytes subjected to stress, allergens, or pathogens, causes the activation of dendritic cells and the secretion of chemokines, which attract type 2 helper T lymphocytes (Th2) to the skin, releasing pro-allergenic cytokines (type 2 inflammation cytokines, such as IL-4, IL-13, IL-5, IL-31).”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among asthmatic patients, there is a prevalence of approximately 40% of CRS with polyposis, and AD is more common among these patients with CRS with nasal polyposis, compared to those with CRS without polyposis.”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the context of chronic rhinosinusitis (CRS), damage to the upper airway epithelial barrier initiates and perpetuates type 2 inflammation, and environmental factors such as viruses and other stimuli generate alarmins such as TSLP, IL-25, and IL-33, which increase nasal inflammation.”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [18]
Experimental — accuracy not yet measured
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
Fokkens, W. J., Lund, V. J., Hopkins, C., Hellings, P. W., Kern, R., Reitsma, S., Toppila-Salmi, S., Bernal-Sprekelsen, M., Mullol, J., Alobid, I., et al. (2020) · Rhinology journal · doi:10.4193/rhin20.600 · Cited by 5,882
Hay fever, hygiene, and household size.
Strachan, D. P. (1989) · BMJ · doi:10.1136/bmj.299.6710.1259 · Cited by 5,054
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926 · cited 1×
“In a recent real-life analysis, severe asthma, based on the European Respiratory Society/American Thoracic Society guidelines (ERS/ATS) [53], demonstrated a frequent association with several type-2 related pathways, including higher blood and sputum eosinophils, indicating that treatments targeting…”
MethodAllergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Beasley, R. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07302-9 · Cited by 3,389
Dweik, R. A., Boggs, P. B., Erzurum, S. C., Irvin, C. G., Leigh, M. W., Lundberg, J. O., Olin, A.-C., Plummer, A. L., & Taylor, D. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.9120-11st · Cited by 2,539
Constitution of the World Health Organization
(1946) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.36.11.1315 · Cited by 2,519 · cited 1×
““Health” was defined in 1948 by the World Health Organization as a state of complete physical, mental, emotional, and social well-being and not only the absence of disease or infirmity [5].”
BackgroundPrevalence of sleep-disordered breathing in the general population: the HypnoLaus study
Heinzer, R., Vat, S., Marques-Vidal, P., Marti-Soler, H., Andries, D., Tobback, N., Mooser, V, Preisig, M., Malhotra, A., Waeber, G., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00043-0 · Cited by 2,481 · cited 1×
“…studies (such as the recent “HypnoLaus”) have shown that the prevalence of moderate-to-severe OSA, also due to the increased sensitivity of modern diagnostic facilities, stands up to 23.4% in women and 49.7% in men, enhancing the public awareness of the global burden of this chronic condition [91].”
BackgroundInfluentialMepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322 · cited 1×
“Moreover, in patients with a peripheral eosinophil count ≥ 500 cells/ µ L, mepolizumab reduced exacerbation rates by 74 and 79% relative to placebo with SC and IV doses, respectively [66].”
BackgroundDupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Castro, M., Corren, J., Pavord, I. D., Maspero, J., Wenzel, S., Rabe, K. F., Busse, W. W., Ford, L., Sher, L., FitzGerald, J. M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804092 · Cited by 1,986 · cited 1×
“…inhibitors of these particular pathways, such as omalizumab (Xolair ® , Genentech USA, Inc., San Francisco, CA, USA and Novartis Pharmaceuticals Corporation, Tokyo, Japan) a recombinant humanized anti-IgE monoclonal antibody and others specific for type-2 cytokines (IL-4, IL-5, and IL-13) [62,63].”
BackgroundType 2 inflammation in asthma — present in most, absent in many
Fahy, J. V. (2015) · Nature Reviews Immunology · doi:10.1038/nri3786 · Cited by 1,654 · cited 1×
“It has been ascertained that type-2 is probably the most common type of asthma, since about 50–70% of asthmatics display an underlying type-2 inflammation pattern, as measured through eosinophils and IgE blood count [52].”
BackgroundPsychometric validity of the 22‐item Sinonasal Outcome Test
Hopkins, C., Gillett, S., Slack, R., Lund, V. J., & Browne, J. P. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01995.x · Cited by 1,621 · cited 1×
“…by a clinician, in recent years several randomized controlled trials and real-life experiences have made use of these tools, including disease-specific questionnaires (e.g., Sino-Nasal Outcome Test-22) and generic ones (e.g., Short Form-36), as reliable endpoints for new drugs [130,131].”
BackgroundDiagnosis and Management of Obstructive Sleep Apnea: A Review
Gottlieb, D. J., & Punjabi, N. M. (2020) · JAMA · doi:10.1001/jama.2020.3514 · Cited by 1,482 · cited 1×
“Obstructive sleep apnea (OSA) is characterized by recurrent episodes of UA occlusion during sleep (apnoeic or hypopneic events) with consequent excessive daytime sleepiness and/or cardiovascular dysfunctions, hence the clinical scenario of OSA syndrome (OSAS) is currently widely accepted [80].”
BackgroundEPOS2020: A Major Step Forward
Fokkens, W. J. (2020) · Rhinology journal · doi:10.4193/rhin20.401 · Cited by 1,240 · cited 3×
“…phenotype, taking into account different endoscopic, radiographic and clinical aspects, several clinical entities have been further proposed in years, including central compartment atopic disease (CCAD), allergic fungal rhinosinusitis (AFRS), or aspirin-exacerbated respiratory disease (AERD) [1].”
BackgroundUnderstanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
Kuruvilla, M. E., Lee, F. E.-H., & Lee, G. B. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8712-1 · Cited by 1,228 · cited 1×
“Even If It was initially considered as “a single entity” disease, the individuation of the etiopathological mechanisms behind this condition allowed a novel definition of a “type-2 related” (or “Th2-high”) and a “type-2 unrelated” (or “Th2-low”) asthma [51].”
BackgroundChronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study
Hastan, D., Fokkens, W. J., Bachert, C., Newson, R. B., Bislimovska, J., Bockelbrink, A., Bousquet, P. J., Brozek, G., Bruno, A., Dahlén, S. E., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02646.x · Cited by 1,112
Lambrecht, B. N., Hammad, H., & Fahy, J. V. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.018 · Cited by 1,039 · cited 1×
“In fact, IL-4 is the key inducer of CD4+ T-helper cell commitment towards a Th2 immunophenotype, whilst IL-13 primarily promotes the development of bronchial inflammation and remodeling, thus enhancing airway hyperresponsiveness [55].”
BackgroundA Review of Key Likert Scale Development Advances: 1995–2019
Jebb, A. T., Ng, V., & Tay, L. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.637547 · Cited by 770 · cited 1×
“The degree or severity of symptoms can be assessed and graded using many different tools: in a Likert-type scale as severe, moderate, mild, or asymptomatic, or as a visual analogue scale (VAS) score giving a measurable continuum (e.g., 0–10 cm) [8,9].”
BackgroundEnaud, R., Prevel, R., Ciarlo, E., Beaufils, F., Wieërs, G., Guery, B., & Delhaes, L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00009 · Cited by 738 · cited 1×
“Traveling from the gastrointestinal to the respiratory tract, the microbiota established in the lung might directly contribute to the pathogenesis of respiratory atopic disorders, from a perspective of a “gut-lung axis” [30].”
BackgroundValidation of a Standardized Version of the Asthma Quality of Life Questionnaire
Juniper, E. F., Buist, A. S., Cox, F. M., Ferrie, P. J., & King, D. R. (1999) · Chest · doi:10.1378/chest.115.5.1265 · Cited by 714 · cited 1×
“…the mean AQLQ score (Asthma Quality of Life Questionnaire, a standardized PRO for asthmatic patients), reduced mean daily albuterol puffs and decreased the total asthma symptom severity score, which included a nocturnal asthma score, morning asthma symptoms, and a daytime asthma symptom score [65].”
BackgroundPrimary health care: Now more than ever
Chan, M. (2012) · UN Chronicle · doi:10.18356/cbabf986-en · Cited by 686
Mercieca-Bebber, R., King, M. T., Calvert, M. J., Stockler, M. R., & Friedlander, M. (2018) · Patient Related Outcome Measures · doi:10.2147/prom.s156279 · Cited by 659
Pathophysiology of atopic dermatitis: Clinical implications
Kim, J., Kim, B. E., & Leung, D. Y. M. (2019) · Allergy and Asthma Proceedings · doi:10.2500/aap.2019.40.4202 · Cited by 635 · cited 1×
“In this context, however, type-2 inflammation plays a dual role, both promoting the Initiation of skin defect as well as the maintenance of the inflammatory process [69].”
BackgroundNitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
Andrabi, S. M., Sharma, N. S., Karan, A., Shahriar, S. M. S., Cordon, B., Ma, B., & Xie, J. (2023) · Advanced Science · doi:10.1002/advs.202303259 · Cited by 602
Type 2 immunity in the skin and lungs
Akdis, C. A., Arkwright, P. D., Brüggen, M.-C., Busse, W., Gadina, M., Guttman‐Yassky, E., Kabashima, K., Mitamura, Y., Vian, L., Wu, J., et al. (2020) · Allergy · doi:10.1111/all.14318 · Cited by 560 · cited 1×
“The product of this immune cascade is the activation of eosinophils (by means of IL-5 and IL-13) and B-cells (through IL-4) [35], resulting in proliferation of Th2 cells, isotype class switching of B cells to produce IgE, and eventually inducing airway hyperreactivity, mucus hyperproduction, as…”
BackgroundHanania, N. A., Alpan, O., Hamilos, D. L., Condemi, J. J., Reyes-Rivera, I., Zhu, J., Rosen, K. E., Eisner, M. D., Wong, D. A., & Busse, W. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-9-201105030-00002 · Cited by 554 · cited 1×
“During 48 weeks of treatment, the rate of protocol-defined asthma exacerbations was significantly reduced for omalizumab compared with placebo, representing a 25% relative reduction [64].”
BackgroundImpact of Air Pollution on Asthma Outcomes
Tiotiu, A. I., Novakova, P., Nedeva, D., Chong-Neto, H. J., Novakova, S., Steiropoulos, P., & Kowal, K. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176212 · Cited by 513
Klimek, L., Bergmann, K.-C., Biedermann, T., Bousquet, J., Hellings, P., Jung, K., Merk, H., Olze, H., Schlenter, W., Stock, P., et al. (2017) · Allergo Journal International · doi:10.1007/s40629-016-0006-7 · Cited by 475 · cited 1×
“The degree or severity of symptoms can be assessed and graded using many different tools: in a Likert-type scale as severe, moderate, mild, or asymptomatic, or as a visual analogue scale (VAS) score giving a measurable continuum (e.g., 0–10 cm) [8,9].”
BackgroundSuárez-Fariñas, M., Tintle, S. J., Shemer, A., Chiricozzi, A., Nograles, K., Cardinale, I., Duan, S., Bowcock, A. M., Krueger, J. G., & Guttman-Yassky, E. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1124 · Cited by 464 · cited 1×
“In addition, elevated levels of IL-13 mRNA have been detected in both lesional and non-lesional skin of AD patients, and the number of IL-13-producing circulating T cells has been closely associated with disease severity [71,72].”
BackgroundPhenotypes and endotypes of adult asthma: Moving toward precision medicine
Kaur, R., & Chupp, G. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.05.031 · Cited by 457 · cited 1×
“This shift involves moving away from a “phenotype-based” definition, in order to embrace an “endotype-based” approach, which has gained significant importance in EPOS2020 [1,3,4].”
BackgroundShi, J. B., Fu, Q. L., Zhang, H., Cheng, L., Wang, Y. J., Zhu, D. D., Lv, W., Liu, S. X., Li, P. Z., Ou, C. Q., et al. (2015) · Allergy · doi:10.1111/all.12577 · Cited by 436
Oxidative stress pathways of air pollution mediated toxicity: Recent insights
Gangwar, R. S., Bevan, G. H., Palanivel, R., Das, L., & Rajagopalan, S. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101545 · Cited by 409 · cited 1×
“Many pollutants, including particulate matter (PM) and ozone (O 3 ) have been shown to upregulate reactive oxygen species, leading to DNA damage and increased oxidative stress and inflammation [45,46].”
BackgroundThe Biology of Eosinophils and Their Role in Asthma
McBrien, C. N., & Menzies-Gow, A. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00093 · Cited by 368 · cited 1×
“Eosinophils can further exacerbate airway remodeling due to their release of TGF-β and cytokines by interactions with mast cells, worsening inflammation and aggravating asthma over time if not managed timely [58].”
BackgroundChronic Rhinosinusitis: Epidemiology and Burden of Disease
DeConde, A. S., & Soler, Z. M. (2016) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2016.30.4297 · Cited by 362
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Silverberg, J. I., Guttman-Yassky, E., Thaçi, D., Irvine, A. D., Stein Gold, L., Blauvelt, A., Simpson, E. L., Chu, C.-Y., Liu, Z., Gontijo Lima, R., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2206714 · Cited by 345 · cited 1×
“…trial #1, the outcome was met in 43.1% of 283 patients in the lebrikizumab group and in 12.7% of 141 patients in the placebo group ( p -value 0.001), whereas in 33.2% of 281 patients in the lebrikizumab group and in 10.8% of 146 patients in the placebo group in trial #2 ( p -value 0.001) [74].”
ResultInfluentialType 2 inflammation in asthma and other airway diseases
Maspero, J., Adir, Y., Al-Ahmad, M., Celis-Preciado, C. A., Colodenco, F. D., Giavina-Bianchi, P., Lababidi, H., Ledanois, O., Mahoub, B., Perng, D.-W., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00576-2021 · Cited by 315 · cited 1×
“The pathological process begins with the inhalation of an irritant (e.g., cold air) or an allergen (e.g., pollen), which then, due to bronchial hypersensitivity, leads to airway inflammation and to an increase in mucus production, creating an obstructive reversible bronchial condition [49,50].”
BackgroundMechanisms and pathogenesis of chronic rhinosinusitis
Kato, A., Schleimer, R. P., & Bleier, B. S. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.02.016 · Cited by 306 · cited 1×
“However, the prevalence of type-2 related CRSwNP has been increasing also in Asia over the past decades [17].”
BackgroundBurden of Disease in Chronic Rhinosinusitis with Nasal Polyps
Bachert, C., Bhattacharyya, N., Desrosiers, M., & Khan, A. H. (2021) · Journal of Asthma and Allergy · doi:10.2147/jaa.s290424 · Cited by 294 · cited 1×
“…UA diseases, whether viewed from a pathophysiological or clinical standpoint, has the potential to mutually amplify the burden of both conditions [11]; hence, the distinction between upper and lower airways is artificial, since the upper and lower respiratory tracts are both components of one,…”
BackgroundWorldwide prevalence of rhinitis in adults: A review of definitions and temporal evolution
Savouré, M., Bousquet, J., Jaakkola, J. J. K., Jaakkola, M. S., Jacquemin, B., & Nadif, R. (2022) · Clinical and Translational Allergy · doi:10.1002/clt2.12130 · Cited by 290
Minoguchi, K., Tazaki, T., Yokoe, T., Minoguchi, H., Watanabe, Y., Yamamoto, M., & Adachi, M. (2004) · Chest · doi:10.1378/chest.126.5.1473 · Cited by 288 · cited 1×
“Moreover, some inflammatory mediators (IL-6, TNF-α ) may induce a damage to the efferent nervous fibers, resulting in a weaker stimulation of the pharyngeal dilatator muscles [86].”
BackgroundEconomics of Chronic Rhinosinusitis
Rudmik, L. (2017) · Current Allergy and Asthma Reports · doi:10.1007/s11882-017-0690-5 · Cited by 270 · cited 1×
“…CRS is estimated to range between $10 and $13 billion per year (e.g., 10.000–13.000 million dollars/year) in the USA, while the overall indirect cost due to CRS-related losses in work productivity is estimated to be in excess of $20 billion per year, for a total of more than $30 billion/year [121].”
BackgroundInfluentialBeyond Host Defense: Emerging Functions of the Immune System in Regulating Complex Tissue Physiology
Rankin, L. C., & Artis, D. (2018) · Cell · doi:10.1016/j.cell.2018.03.013 · Cited by 269 · cited 1×
“…of infections sustained by extracellular pathogens in Western countries and, more recently, in developing countries would be the origin of the disruption of the delicate equilibrium between type-1 (IL-2, IL-12, TNF-α , IFN-γ , lymphotoxin-α ) and type-2 (IL-4, IL-5, IL-9, IL-13) inflammation [21].”
BackgroundDietz de Loos, D., Lourijsen, E. S., Wildeman, M. A. M., Freling, N. J. M., Wolvers, M. D. J., Reitsma, S., & Fokkens, W. J. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.12.986 · Cited by 268
Nagarkar, D. R., Poposki, J. A., Tan, B. K., Comeau, M. R., Peters, A. T., Hulse, K. E., Suh, L. A., Norton, J., Harris, K. E., Grammer, L. C., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.005 · Cited by 266 · cited 1×
“In support of its role in CRSwNP pathogenesis, the concentration of TSLP mRNA as well as its activity were found to be significantly higher in NPs tissue from patients with CRSwNP compared with uncinate tissue from patients with CRS or control subjects [34].”
ResultSwarbrick, M. (2006) · Psychiatric Rehabilitation Journal · doi:10.2975/29.2006.311.314 · Cited by 243 · cited 1×
“This method, subsequently endorsed by esteemed associations such as the American Psychological Association (APA), encompassed eight different but mutually co-dependent dimensions of wellness: emotional, occupational, social, spiritual, intellectual, environmental, financial, and physical [79].”
MethodThe burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study
García-Marcos, L., Asher, M. I., Pearce, N., Ellwood, E., Bissell, K., Chiang, C.-Y., El Sony, A., Ellwood, P., Marks, G. B., Mortimer, K., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02866-2021 · Cited by 224
Konkel, J. E., Zhang, D., Zanvit, P., Chia, C., Zangarle-Murray, T., Jin, W., Wang, S., & Chen, W. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.015 · Cited by 220 · cited 1×
“One more molecule that is crucial for the pathogenesis or airway type-2 related disorders is the transforming growth factor-β (TGF-β ) [38,39].”
Edwards, M. R., Strong, K., Cameron, A., Walton, R. P., Jackson, D. J., & Johnston, S. L. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.025 · Cited by 212 · cited 1×
“Indeed, viral-induced damage to the epithelial barrier results in overexpression of Th-2 related cytokines such as IL-33, IL-25, and Thymic Stromal Lymphopoietin (TSLP), eventually exacerbating atopy [27].”
BackgroundA comprehensive review of obstructive sleep apnea.
Abbasil, A., Gupta, S. S., Sabharwal, N., Meghrajani, V., Sharma, S., Kamholz, S. L., & Kupfer, Y. Y. (2021) · PubMed · doi:10.5935/1984-0063.20200056 · Cited by 173
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
Pelaia, C., Heffler, E., Crimi, C., Maglio, A., Vatrella, A., Pelaia, G., & Canonica, G. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.851940 · Cited by 172 · cited 1×
“IL-5 and IL-13 both play a role in B-cell class switching and IgE production, leading to the degranulation of eosinophils and mast cells and subsequent release of pro-inflammatory mediators as well as barrier disruption and tissue remodeling [57].”
BackgroundSelf-citationThe Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
Marone, G., Granata, F., Pucino, V., Pecoraro, A., Heffler, E., Loffredo, S., Scadding, G. W., & Varricchi, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01387 · Cited by 171 · cited 1×
“Moreover, IL-13-mediated damage to the epithelial barriers is also associated with the development of mucus plugs as a consequence of mucus hyperproduction [56].”
BackgroundSelf-citationOn behalf of the CRES group, Philpott, C. M., Erskine, S., Hopkins, C. L., Kumar, N., Anari, S., Kara, N., Sunkaraneni, S., Ray, J., Clark, A., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0823-y · Cited by 168 · cited 1×
“In this cohort composed by 1470 participants, prevalence of asthma ranged from 21% in CRSsNP through 47% in CRSwNP to 73% in AFRS [118].”
BackgroundThe burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study
Mortimer, K., Lesosky, M., García-Marcos, L., Asher, M. I., Pearce, N., Ellwood, E., Bissell, K., El Sony, A., Ellwood, P., Marks, G. B., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02865-2021 · Cited by 167 · cited 1×
“The reported overall prevalence rates were 4.4% for asthma and 9.9% for atopic dermatitis (AD), with significant variations observed both between and within countries (ranging from 0.9% to 29.0% for asthma and 1.6% to 29.5% for AD, respectively) [115].”
BackgroundInfluentialEpidemiology of Allergic Rhinitis in Children: A Systematic Review and Meta-Analysis
Licari, A., Magri, P., De Silvestri, A., Giannetti, A., Indolfi, C., Mori, F., Marseglia, G. L., & Peroni, D. (2023) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2023.05.016 · Cited by 165 · cited 1×
“…metanalysis by Licari et al., the prevalence of allergic rhinitis in pediatric population raised from 8.39% in the period 2012–2015 to 19.87% in the period 2016–2022, possibly due to both extrinsic (e.g., microenvironmental) and intrinsic (e.g., type-2 dysregulated immune response) factors [109].”
BackgroundInfluentialPathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes
Cao, P.-P., Wang, Z.-C., Schleimer, R. P., & Liu, Z. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.10.014 · Cited by 154 · cited 1×
“The classification of CRS in CRSw/sNP, based solely on the presence of nasal polyps (NPs), despite being still frequently used, does not provide an appropriate understanding of the disease in order to propose adequate treatment options [15].”
BackgroundOjiaku, C. A., Yoo, E., & Panettieri, R. A. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0307tr · Cited by 153
Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes
Promsopa, C., Kansara, S. G., Citardi, M. J., Fakhri, S., Porter, P., & Luong, A. (2015) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21674 · Cited by 150 · cited 1×
“In further support of the pathophysiological basis that connects type-2 related diseases, the prevalence of CRS and asthma has been linked, with up to 50% asthma prevalence in CRSwNP patients [117].”
BackgroundAtopic dermatitis in children and adults
Wollenberg, A., Werfel, T., Ring, J., Ott, H., Gieler, U., & Weidinger, S. (2023) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2023.0011 · Cited by 150
Cleaning up the hygiene hypothesis
Scudellari, M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700688114 · Cited by 148
The Hygiene Hypothesis – Learning From but Not Living in the Past
Pfefferle, P. I., Keber, C. U., Cohen, R. M., & Garn, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635935 · Cited by 147 · cited 1×
“Due to several advances in research, the Strachan’s hypothesis has been criticized and readapted over the years [23–25].”
BackgroundIL4Rα Mutations Are Associated with Asthma Exacerbations and Mast Cell/IgE Expression
Wenzel, S. E., Balzar, S., Ampleford, E., Hawkins, G. A., Busse, W. W., Calhoun, W. J., Castro, M., Chung, K. F., Erzurum, S., Gaston, B., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-909oc · Cited by 142 · cited 1×
“Indeed, genetic population studies showed that gain-of-function single nucleotide polymorphisms of the IL-4 receptor gene IL4R α are associated with severe asthma exacerbations, lower lung function, and increased mast cell-related tissue inflammation [60].”
BackgroundBlome, C., Radtke, M. A., Eissing, L., & Augustin, M. (2016) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0171-3 · Cited by 142 · cited 1×
“One of the most commonly used skin-specific tools to assess QoL in AD patients is the Dermatology Life Quality Index in adults and related questionnaires for children, such as the Children’s Dermatology Life Quality Index [137].”
BackgroundCampos, A. I., García-Marín, L. M., Byrne, E. M., Martin, N. G., Cuéllar-Partida, G., & Rentería, M. E. (2020) · Nature Communications · doi:10.1038/s41467-020-14625-1 · Cited by 135 · cited 1×
“…primary/simple snoring in middle-aged men has been reported in the range of 25–50%, with several differences between different geographical areas [89,90], whereas recent epidemiological studies (such as the recent “HypnoLaus”) have shown that the prevalence of moderate-to-severe OSA, also due to…”
ResultThe Role of Type 2 Inflammation in the Pathogenesis of Asthma Exacerbations
Dunican, E. M., & Fahy, J. V. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201506-377aw · Cited by 130 · cited 2×
“To overcome the outdated “phenotype-driven” in favor of an “endotype-driven” classification of CRS, it is imperative to examine each patient comprehensively, considering clinical, endoscopic, radiological, and immunological perspectives [16].”
BackgroundThe invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis
Borsoi, L., Armeni, P., Donin, G., Costa, F., & Ferini‐Strambi, L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268677 · Cited by 130 · cited 1×
“Moreover, the authors emphasized that these figures were notably higher than the current costs incurred for the diagnosis and treatment of obstructive sleep apnea (OSA), which amount to EUR 234 million per year [123].”
BackgroundTranscriptional Effects of Ozone and Impact on Airway Inflammation
Mumby, S. E., Chung, K. F., & Adcock, I. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01610 · Cited by 129 · cited 1×
“Many pollutants, including particulate matter (PM) and ozone (O 3 ) have been shown to upregulate reactive oxygen species, leading to DNA damage and increased oxidative stress and inflammation [45,46].”
BackgroundImmune Mediators in Allergic Rhinitis and Sleep
Krouse, H. J., Davis, J. E., & Krouse, J. H. (2002) · Otolaryngology–Head and Neck Surgery · doi:10.1067/mhn.2002.125300 · Cited by 120 · cited 1×
“In a comparative study by Krause et al., levels of pro-allergic serum cytokines in allergic subjects correlated with increased latency to rapid eye movement sleep, decreased time in rapid eye movement sleep, and decreased latency to sleep onset [85].”
BackgroundThe Developing Microbiome From Birth to 3 Years: The Gut-Brain Axis and Neurodevelopmental Outcomes
Laue, H. E., Coker, M. O., & Madan, J. C. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.815885 · Cited by 120
Canonica, G. W., Malvezzi, L., Blasi, F., Paggiaro, P., Mantero, M., Senna, G., Heffler, E. M., Bonavia, M., Caiaffa, P., Calabrese, C., et al. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.105947 · Cited by 117 · cited 1×
“…more frequent in patients with CRSwNP than in subjects without NPs. Finally, patients with CRSwNP had a significantly higher number of asthma exacerbations per year, greater intake of oral corticosteroids (OCS) and were more likely to be systemic corticosteroids users on the long term [61].”
BackgroundSelf-citationMcLoughlin, R., Berthon, B. S., Rogers, G. B., Baines, K. J., Leong, L. E. X., Gibson, P. G., Williams, E. J., & Wood, L. G. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.07.048 · Cited by 115 · cited 1×
“Accordingly, McLoughlin et al. applied soluble inulin to asthmatics in a 7 days placebo-controlled-trial, observing a significantly reduced number of eosinophils in the sputum as well as an improved global asthma control in patients orally treated with inulin [29].”
BackgroundImpact of atopic dermatitis on quality of life in adults: a systematic review and meta‐analysis
Birdi, G., Cooke, R., & Knibb, R. C. (2020) · International Journal of Dermatology · doi:10.1111/ijd.14763 · Cited by 115 · cited 1×
“Nevertheless, authors noticed high heterogeneity in the tools used to measure the disease severity across different studies, therefore further validation analysis is warranted in order to cross-culturally validate definite reliable PROs in patients with AD [138].”
MethodA Review of Classification Schemes for Chronic Rhinosinusitis with Nasal Polyposis Endotypes
Dennis, S. K., Lam, K. K., & Luong, A. (2016) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.32 · Cited by 109 · cited 1×
“This shift involves moving away from a “phenotype-based” definition, in order to embrace an “endotype-based” approach, which has gained significant importance in EPOS2020 [1,3,4].”
BackgroundA Diagnostic Dilemma for Chronic Rhinosinusitis: Definition Accuracy and Validity
Stankiewicz, J. A., & Chow, J. M. (2002) · American Journal of Rhinology · doi:10.1177/194589240201600404 · Cited by 106
Asthma outcomes improve with continuous positive airway pressure for obstructive sleep apnea
Serrano‐Pariente, J., Plaza, V., Soriano, J. B., Mayos, M., López-Viña, A., Picado, C., Vigil, L., & the CPASMA Trial Group (2016) · Allergy · doi:10.1111/all.13070 · Cited by 106
Impact of anxiety and depression on respiratory symptoms
Leander, M., Lampa, E., Rask-Andersen, A., Franklin, K., Gislason, T., Oudin, A., Svanes, C., Torén, K., & Janson, C. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.09.007 · Cited by 103 · cited 1×
“Similarly, Leander et al. demonstrated a statistical correlation between anxiety, depression, and asthmatic symptoms, including attacks of shortness of breath after activity, impairing the QoL [136].”
BackgroundThe Socioeconomic Cost of Chronic Rhinosinusitis Study
Wahid, N., Smith, R. A., Clark, A., Salam, M., & Philpott, C. M. (2020) · Rhinology Journal · doi:10.4193/rhin19.424 · Cited by 97 · cited 1×
“Concerning the indirect costs of CRS, the average total missed workdays in CRS patients were estimated annually at 18.7 per patient [122].”
BackgroundInfluentialHeffler, E. M., Carpagnano, G. E., Favero, E., Guida, G., Maniscalco, M., Motta, A., Paoletti, G., Rolla, G., Baraldi, E., Pezzella, V., et al. (2020) · Multidisciplinary Respiratory Medicine · doi:10.4081/mrm.2020.36 · Cited by 95 · cited 1×
“…recent research suggested that the inflammatory microenvironment results in upregulation of arginase activity, thus limiting L-arginine bioavailability for iNOS, eventually contributing to further free radical formation (e.g., peroxinitrite) with enhanced cytotoxic action in the airways [99].”
BackgroundSelf-citationThe Hygiene Hypothesis and New Perspectives—Current Challenges Meeting an Old Postulate
Garn, H., Potaczek, D. P., & Pfefferle, P. I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637087 · Cited by 95 · cited 1×
“Type-2 induced interleukins, although being phylogenetically directed against helminths, when dysregulated may promote the cross-reaction of immunological reactivity against self-epitopes, thus increasing the incidence of both autoimmune and allergic diseases [22].”
BackgroundPatient-reported outcome measures for asthma: a systematic review
Worth, A., Hammersley, V., Knibb, R. C., Flokstra-de-Blok, B., DunnGalvin, A., Walker, S. M., Dubois, A. E. J., & Sheikh, A. (2014) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2014.20 · Cited by 93 · cited 1×
“…et al., PROs found to be sufficiently well validated to offer promise for use in clinical settings for the assessment of QoL in asthmatic patients were the Asthma Quality of Life Questionnaire (AQLQ) and mini-AQLQ for adults, and Pediatric Asthma Quality of Life Questionnaire for children [133].”
MethodTissue-specific immunity in helminth infections
Vacca, F., & Le Gros, G. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00531-w · Cited by 86
Unveiling the true costs and societal impacts of moderate‐to‐severe atopic dermatitis in Europe
Augustin, M., Misery, L., von Kobyletzki, L., Hita, J. C. A., Mealing, S., & Redding, M. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18168 · Cited by 83 · cited 1×
“…of moderate-to-severe forms of AD across Europe have been estimated at EUR 30 billion per year; EUR 15.2 billion related to missed workdays or reduced work productivity, EUR 10.1 billion related to direct medical costs and EUR 4.7 billion related to personal expenditure of patients/families [127].”
BackgroundInfluentialDoes Upper Airway Muscle Injury Trigger a Vicious Cycle in Obstructive Sleep Apnea? A Hypothesis
Petrof, B. J., Hendricks, J. C., & Pack, A. I. (1996) · Sleep · doi:10.1093/sleep/19.6.465 · Cited by 75 · cited 1×
“Accordingly, Boyd et al. demonstrated a significant increase in inflammatory T-cell infiltration of the UA in patients with OSA, which encompassed both the mucosal and muscular layers [87].”
BackgroundAssociation Between Insomnia and Asthma Burden in the Severe Asthma Research Program (SARP) III
Luyster, F. S., Strollo, P. J., Holguín, F., Castro, M., Dunican, E. M., Fahy, J. V., Gaston, B. M., Israel, E., Jarjour, N. N., Mauger, D. T., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.09.020 · Cited by 75 · cited 1×
“…of insomnia was associated with higher levels of depression, anxiety symptoms and poorer quality of life, as well as a 2.4-fold increased risk of having a not well-controlled asthma and a 1.5-fold increased risk for asthma-related health care utilization compared to patients without insomnia [135].”
BackgroundInfluentialEnvironmental air pollution and chronic rhinosinusitis: A systematic review
Leland, E. M., Vohra, V., Seal, S. M., Zhang, Z., & Ramanathan, M. (2022) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.774 · Cited by 75 · cited 1×
“…pollutant exposure, particularly PM, to be associated with higher odds of developing CRS. Increased air pollution was even associated with worsened disease severity and detectable histopathologic changes, such as eosinophilic aggregates, and Charcot–Leyden crystals in patients with CRSwNP [47,48].”
BackgroundDoroudchi, A., Pathria, M., & Modena, B. D. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.10.016 · Cited by 74 · cited 1×
“…inhibitors of these particular pathways, such as omalizumab (Xolair ® , Genentech USA, Inc., San Francisco, CA, USA and Novartis Pharmaceuticals Corporation, Tokyo, Japan) a recombinant humanized anti-IgE monoclonal antibody and others specific for type-2 cytokines (IL-4, IL-5, and IL-13) [62,63].”
BackgroundWatelet, J., Cindy, Perez-Novo, C. A., Gevaert, P., Cauwenberge, P. V., & Bachert, C. (2004) · American Journal of Rhinology · doi:10.1177/194589240401800502 · Cited by 72 · cited 1×
“TGF-β is a key factor in the remodeling process found in sinonasal mucosa with CRS; specifically, TGF-β pathways were found to be upregulated in CRSsNP and downregulated in CRSwNP [40].”
BackgroundBaraldi, E., Azzolin, N. M., Carra', S., Dario, C., Marchesini, L., & Zacchello, F. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90308-0 · Cited by 69 · cited 1×
“Similarly, at a nasal level, a previous study by Baraldi et al. demonstrated that intranasal steroids significantly reduced nNO levels in children with perennial allergic rhinitis, thus speculating a possible role for nNO measurement in type-2 related nasal conditions [102].”
ResultA new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach
Singh, J., Lee, Y., & Kellum, J. A. (2022) · Critical Care · doi:10.1186/s13054-022-04075-0 · Cited by 69 · cited 1×
“Whenever it exceeds the physiological concentrations, NO has been unambiguously proposed as a marker of systemic inflammation [106].”
BackgroundThe hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis
Napolitano, M., di Vico, F., Ruggiero, A., Fabbrocini, G., & Patruno, C. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1165098 · Cited by 65 · cited 1×
“In addition, elevated levels of IL-13 mRNA have been detected in both lesional and non-lesional skin of AD patients, and the number of IL-13-producing circulating T cells has been closely associated with disease severity [71,72].”
BackgroundNasal Obstruction and Sleep-Disordered Breathing: A Study Using Acoustic Rhinometry
Morris, L. G., Burschtin, O., Lebowitz, R. A., Jacobs, J. B., & Lee, K. C. (2005) · American Journal of Rhinology · doi:10.1177/194589240501900106 · Cited by 63 · cited 1×
“Finally, a positive correlation between nasal obstruction (as measured by acoustic rhinometry) and the Respiratory Disturbance Index (which includes apneic, hypopneic episodes as well as respiratory efforts-associated arousals) has been demonstrated in nonobese patients [84].”
BackgroundImpact of Nasal Obstruction on Obstructive Sleep Apnea
Friedman, M., Maley, A., Kelley, K., Leesman, C., Patel, A., Pulver, T., Joseph, N., & Catli, T. (2011) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599811400977 · Cited by 60 · cited 1×
“On the other hand, no significant results were observed for patients with severe OSA, who are most likely to present a multilevel obstruction, where the nasal airway is only a cofactor of a more heterogeneous condition [83].”
BackgroundKallikrein 7 Promotes Atopic Dermatitis-Associated Itch Independently of Skin Inflammation
Guo, C. J., Mack, M. R., Oetjen, L. K., Trier, A. M., Council, M. L., Pavel, A. B., Guttman-Yassky, E., Kim, B. S., & Liu, Q. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.10.022 · Cited by 59
Khan, A. H., Gouia, I., Kamat, S., Johnson, R. R., Small, M., & Siddall, J. (2023) · Lung · doi:10.1007/s00408-023-00603-z · Cited by 58 · cited 1×
“Moreover, 24%, 36%, and 16% of patients suffering from asthma, CRSwNP and AD had at least two type-2 related disorders, respectively [120].”
BackgroundRelease of Type 2 Cytokines by Epithelial Cells of Nasal Polyps
Boita, M., Bucca, C. B., Riva, G., Heffler, E. M., & Rolla, G. (2016) · Journal of Immunology Research · doi:10.1155/2016/2643297 · Cited by 55 · cited 1×
“Both IL-4 and IL-13 induce the abovementioned conditioned state of macrophages, a typical feature of CRSwNP [36,37].”
BackgroundSelf-citationAsthma exacerbation related to viral infections: An up to date summary
Adeli, M., El-Shareif, T., & Hendaus, M. A. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_86_19 · Cited by 55 · cited 1×
“Epidemiologic studies provided evidence that several viral pathogens, although inducing a Th-1 related immune response, were not protective against allergic diseases, and, in many cases, even increased the risk [26].”
BackgroundSircu, V., Colesnic, S., Covanţev, S., Corlateanu, O., Sukhotko, A. S., Popovici, C., & Corlăteanu, A. (2023) · Clocks & Sleep · doi:10.3390/clockssleep5020025 · Cited by 52 · cited 1×
“…further reduction in tissue oxygen release, resulting in intermittent hypoxia, high sympathetic nervous activity, hypertension, endothelial dysfunction, oxidative stress, inflammation, and accelerated atherosclerosis, which have been investigated and confirmed in several population studies [94–96].”
ResultSevere asthma is related to high societal costs and decreased health related quality of life
Jansson, S., Bäckman, H., Andersson, M., Telg, G., Lindberg, A., Stridsman, C., Lundbäck, B., & Rönmark, E. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2019.105860 · Cited by 49 · cited 1×
“Furthermore, higher direct costs were proven in patients regularly on treatment with OCS compared to those who were under different medications [126].”
BackgroundHuman type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL‐13
Sugita, K., Altunbulakli, C., Morita, H., Sugita, A., Kubo, T., Kimura, R., Goto, H., Yamamoto, O., Rückert, B., Akdis, M., et al. (2019) · Allergy · doi:10.1111/all.13935 · Cited by 47 · cited 1×
“The upregulation of IL-4 and IL-13 has been demonstrated to inhibit the expression of epidermal proteins, such as FLG, loricrin, and involucrin, leading to skin barrier defects [70].”
BackgroundAl-Digheari, A., Mahboub, B., Tarraf, H., Yücel, T., Annesi‐Maesano, I., Doble, A., Lahlou, A., Tariq, L., Aziz, F., & Hasnaoui, A. E. (2018) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-018-0298-x · Cited by 45
The “Hygiene Hypothesis” and the Lessons Learnt From Farm Studies
von Mutius, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635522 · Cited by 45
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis
Pelaia, C., Pelaia, G., Maglio, A., Tinello, C., Gallelli, L., Lombardo, N., Terracciano, R., & Vatrella, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103371 · Cited by 45 · cited 1×
“Consequently, the concept of inflammatory endotype, particularly type 2 inflammation in our case, has been introduced in this field [2].”
BackgroundConteville, L. C., Oliveira-Ferreira, J., & Vicente, A. C. P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01743 · Cited by 44
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps
Heffler, E. M., Malvezzi, L., Boita, M., Brussino, L., VIRGILIO, A. D., Ferrando, M., Puggioni, F., Racca, F., Stomeo, N., Spriano, G., et al. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1512407 · Cited by 43 · cited 1×
“Both IL-4 and IL-13 induce the abovementioned conditioned state of macrophages, a typical feature of CRSwNP [36,37].”
BackgroundSelf-citationClinical factors affecting quality of life of patients with asthma
Uchmanowicz, I., Uchmanowicz, B., Panaszek, B., & Rosińćzuk, J. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s103043 · Cited by 41 · cited 1×
“The Quality of Life scores in the “Emotional function” and “Environmental stimuli” subscale of the AQLQ decreased significantly as time from onset increased, thus emphasizing the importance of early diagnosis and management of asthma related symptoms to stop the progression of disease [134].”
BackgroundAmbrosino, P., Molino, A., Spedicato, G. A., Parrella, P., Formisano, R., Motta, A., Minno, M. N. D. D., & Maniscalco, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010200 · Cited by 41 · cited 1×
“…develops in CRSwNP is responsible for a decrease in nNO measurement compared to both CRSsNP patients and healthy controls, mainly as a result of the ostiomeatal blockage by polyps, which reduces NO passage from sinuses to the nasal lumen, despite its increased synthesis due to inflammation [103].”
Värendh, M., Andersson, M., Bjørnsdottir, E., Hrubos‐Strøm, H., Johannisson, A., Arnardottir, E. S., Gislason, T., & Juliusson, S. (2018) · Journal of Sleep Research · doi:10.1111/jsr.12631 · Cited by 39
Alterations of nasal microbiome in eosinophilic chronic rhinosinusitis
Liang, Y., Xie, R., Xiong, X., Hu, Z., Mao, X., Wang, X., Zhang, J., Sun, P., Yue, Z., Wang, W., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.031 · Cited by 39 · cited 1×
“As abovementioned, other factors such as the microbiome and genetic predisposition play a pivotal role [43,44].”
BackgroundChronic Rhinosinusitis Is an Independent Risk Factor for OSA in World Trade Center Responders
Sunderram, J., Weintraub, M., Black, K., Alimokhtari, S., Twumasi, A., Sanders, H., Udasin, I., Harrison, D., Chitkara, N., de la Hoz, R. E., et al. (2019) · Chest · doi:10.1016/j.chest.2018.10.015 · Cited by 38 · cited 1×
“…the disaster on 11 September 2001, patients who had developed or worsened CRS, possibly due to inhalation of environmental pollutants, presented a statistically significant higher risk for OSA with an odds-ratio of 1.80 ( p -value = 0.006), after adjustment for possible confounding factors [92].”
BackgroundInfluentialMullol, J., Maldonado, M., Castillo, J. A., Miguel-Blanco, C., Davila, I. J., Domínguez‐Ortega, J., & Blanco‐Aparicio, M. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.04.039 · Cited by 37 · cited 1×
“…from a pathophysiological or clinical standpoint, has the potential to mutually amplify the burden of both conditions [11]; hence, the distinction between upper and lower airways is artificial, since the upper and lower respiratory tracts are both components of one, “united airway” system [12–14].”
BackgroundGarcía-Reyes, M. M., Zumaya-Pérez, L. C., Pastelin‐Palacios, R., & Moreno‐Eutímio, M. A. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01147-5 · Cited by 36
The direct and indirect costs of adult atopic dermatitis
Manjelievskaia, J., Boytsov, N. N., Brouillette, M. A., Onyekwere, U., Pierce, E. J., Goldblum, O. M., & Bonafede, M. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.10.1416 · Cited by 35 · cited 1×
“Unadjusted annual health care costs in 2018 were $4979 higher for adults with atopic dermatitis ($14,603) than for the matched controls ($9624), driven by outpatient services and pharmacy [128].”
BackgroundKambara, R., Minami, T., Akazawa, H., Tsuji, F., Sasaki, T., Inohara, H., & Horii, A. (2017) · International Archives of Allergy and Immunology · doi:10.1159/000479387 · Cited by 34 · cited 1×
“According to recent research by Kambara et al., significantly higher FeNO values were observed in non-asthmatic CRSwNP patients than in CRSsNP, whereas no significant difference in FeNO was observed between patients with CRSwNP with and without asthma [101].”
ResultCarrer, M., Crosby, J. R., Sun, G., Zhao, C., Damle, S. S., Kuntz, S., Monia, B. P., Hart, C. E., & Grossman, T. R. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0257oc · Cited by 34
Lechner, M., Breeze, C. E., Ohayon, M. M., & Kotecha, B. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2018.08.029 · Cited by 29 · cited 1×
“…snoring in middle-aged men has been reported in the range of 25–50%, with several differences between different geographical areas [89,90], whereas recent epidemiological studies (such as the recent “HypnoLaus”) have shown that the prevalence of moderate-to-severe OSA, also due to…”
ResultNeural Regulation of Interactions Between Group 2 Innate Lymphoid Cells and Pulmonary Immune Cells
Chen, W., Shu, Q., & Fan, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576929 · Cited by 29 · cited 1×
“In detail, type-2 immunity induces a complex response involving granulocytes (eosinophils, basophils), mastocytes, type-2 innate lymphoid cells (ILC2), IL-4-and/or IL-13-conditioned macrophages and T helper 2 (Th2) cells [18].”
BackgroundNasal Nitric Oxide in Relation to Quality-of-life Improvements after Endoscopic Sinus Surgery
Fu, C., Huang, C., Chen, Y.-W., Chang, P., & Lee, T. (2015) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2015.29.4249 · Cited by 28 · cited 1×
“Nevertheless, nNO normalization has been demonstrated after both medical and surgical opening of sinonasal ostia, thus providing evidence of its possible application as a marker of treatment response [104].”
BackgroundVelasquez, N., Gardiner, L. A., Cheng, T. Z., Moore, J. A., Boudreau, R. M., Presto, A. A., & Lee, S. E. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22884 · Cited by 28 · cited 1×
“5 , black carbon, and nitrogen dioxide, which eventually resulted in higher CRS severity as measured by an increased need for chronic OCS treatment [124].”
BackgroundFrøssing, L., Klein, D. K., Hvidtfeldt, M. W., Obling, N., Telg, G., Erjefalt, J. S., Bødtger, U. C. S., & Porsbjerg, C. M. (2022) · ERJ Open Research · doi:10.1183/23120541.00483-2022 · Cited by 27
Care for Patients with Type-2 Chronic Rhinosinusitis
Giunta, G., Pirola, F., Giombi, F., Muci, G., Pace, G. M., Heffler, E. M., Paoletti, G., Puggioni, F., Cerasuolo, M., Ferreli, F., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040618 · Cited by 25 · cited 1×
“This collaborative approach aims to provide the most effective diagnostic and therapeutic strategies for the patient, especially in an era where emerging therapeutic interventions, such as biologic agents, are shaping the landscape of managing type-2 related disorders of the airways [78].”
BackgroundSelf-citationChange in Asthma Control Over Time: Predictors and Outcomes
Schatz, M. X., Zeiger, R. S., Yang, S.-J., Chen, W., Crawford, W., Sajjan, S., & Allen‐Ramey, F. (2013) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.07.016 · Cited by 24 · cited 1×
“…of 1267 asthmatics enrolled by Schatz et al., patients with well-controlled asthma at baseline were significantly more likely to maintain well-controlled asthma over the following year (76.2–80.4%), rather than patients with uncontrolled asthma at baseline (33.5–36.9%; p -value < 0.001) [59].”
BackgroundInfluentialShieh, J., Tsai, Y., Chao‐Yun, J., & Wu, W. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27718 · Cited by 24
Mouth opening/breathing is common in sleep apnea and linked to more nocturnal water loss
Su, V. Y., Chou, K., Tseng, C.-H., Kuo, C., Su, K., Perng, D., Chen, Y., & Chang, S.-C. (2022) · Biomedical Journal · doi:10.1016/j.bj.2022.05.001 · Cited by 24
Li, J., Jiao, J., Gao, Y., Zhang, Y., & Zhang, L. (2019) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-019-0389-3 · Cited by 23 · cited 1×
“TSLP triggers dendritic cell-mediated type-2 inflammatory responses and enhances type-2 cytokine production in mast cells [33].”
BackgroundAlemayehu, D., & Cappelleri, J. C. (2012) · PubMed Central · Cited by 22
Leroy Hood Looks Forward to P4 Medicine: Predictive, Personalized, Preventive, and Participatory
Schmidt, C. R. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju416 · Cited by 20 · cited 1×
“P Medicine” (Prediction, Prevention, Personalization, Participation), introduced by the molecular biologist and oncologist Leroy Hood, which is especially suited for patients affected by chronic conditions such as airways type-2 related disorders [129].”
BackgroundMashaqi, S., & Badr, M. S. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7890 · Cited by 20 · cited 1×
“…further reduction in tissue oxygen release, resulting in intermittent hypoxia, high sympathetic nervous activity, hypertension, endothelial dysfunction, oxidative stress, inflammation, and accelerated atherosclerosis, which have been investigated and confirmed in several population studies [94–96].”
ResultPaoletti, G., Casini, M., Malvezzi, L., Pirola, F., Russo, E., Nappi, E., Muci, G. Q., Montagna, C., Messina, M., Ferri, S., et al. (2022) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0851 · Cited by 20 · cited 1×
“Moreover, Paoletti et al. demonstrated the effectiveness of anti-IL-4 receptor alpha monoclonal antibody (dupilumab), proving a rapid improvement in nNO values and other markers of disease severity as early as 15 days after the initiation of treatment [105].”
BackgroundSelf-citationMyopathy of the upper airway in snoring and obstructive sleep apnea
Shah, F. K., & Stål, P. (2022) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.782 · Cited by 19 · cited 1×
“Moreover, muscle changes mirroring both myopathy and neuropathy have been shown coexisting in biopsies from the soft palate of OSA patients [88].”
BackgroundRadiological Versus Clinical 1‐Year Outcomes of Dupilumab in Refractory CRSwNP : A Real‐Life Study
Giombi, F., Pace, G. M., Nappi, E., Giunta, G., Muci, G., Pirola, F., Ferreli, F., Heffler, E. M., Paoletti, G., Giannitto, C., et al. (2023) · The Laryngoscope · doi:10.1002/lary.31238 · Cited by 19 · cited 1×
“…by a clinician, in recent years several randomized controlled trials and real-life experiences have made use of these tools, including disease-specific questionnaires (e.g., Sino-Nasal Outcome Test-22) and generic ones (e.g., Short Form-36), as reliable endpoints for new drugs [130,131].”
BackgroundSelf-citationBlanco‐Aparicio, M., Domínguez‐Ortega, J., Cisneros, C., Colás, C., Maldonado, F. C., del Cuvillo, A., Alobid, I., Quirce, S., & Mullol, J. (2023) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-023-00780-9 · Cited by 18
Plant, A., & Ardern‐Jones, M. R. (2021) · Clinical Medicine · doi:10.7861/clinmed.2021-0280 · Cited by 17 · cited 1×
“The epidermis plays a crucial role in the pathogenesis of the disease, since it acts as a physical and functional barrier, and skin surface defects are the most significant pathologic findings in AD [68].”
BackgroundWadee, Z. A., Ooi, S. L., & Pak, S. C. (2022) · Biomedicines · doi:10.3390/biomedicines10092273 · Cited by 17 · cited 1×
“In particular, according to a recent meta-analysis by Al Wadee et al., OSA patients showed significantly reduced serum magnesium levels, which correlated with worsening of cardiovascular risk biomarkers (e.g., C-reactive protein, ischemia-modified albumin, carotid intima-media thickness) [97].”
Panek, M., Stawiski, K., Kaszkowiak, M., & Kuna, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.746360 · Cited by 16
Chronic Rhinosinusitis and the Increased Incidence of Atopic Dermatitis
Son, D.-S., Cho, M., & Kim, D.-K. (2022) · American Journal of Rhinology & Allergy · doi:10.1177/19458924221090050 · Cited by 15 · cited 1×
“As expected, no increased risk was observed in the CRS group for developing non-type-2 related dermatologic conditions, such as vitiligo or psoriasis, compared to patients without CRS [119].”
BackgroundMiettinen, M. E., Honkanen, J. K., Niinistö, S., Vaarala, O., Virtanen, S. M., Knip, M., & the DIABIMMUNE Study Group (2021) · Diabetologia · doi:10.1007/s00125-021-05612-2 · Cited by 12
Join or Leave the Club: Jagged1 and Notch2 Dictate the Fate of Airway Epithelial Cells
Kuchibhotla, V. N. S., & Heijink, I. H. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0104ed · Cited by 10 · cited 1×
“…Jag1 and subsequent nuclear translocation of the Notch2 intracellular domain has been observed to induce bronchial epithelial dysfunction by increasing the differentiation of club cells into goblet cells rather than ciliated cells, hence promoting mucus plugs formation and airway obstruction [75].”
BackgroundPrevalence of familial link in patients affected by chronic rhinosinusitis with nasal polyposis
Giombi, F., Carrón‐Herrero, A., Pirola, F., Paoletti, G., Nappi, E., Russo, E., VIRGILIO, A. D., Mercante, G., Canonica, G. W., Spriano, G., et al. (2022) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23049 · Cited by 5 · cited 1×
“As abovementioned, other factors such as the microbiome and genetic predisposition play a pivotal role [43,44].”
BackgroundSelf-citationBronchodilator reversibility in patients with asthma and persistent airflow limitation
Crisafulli, E., Sartori, G., Patruno, V., & Fantin, A. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00363-0 · Cited by 4 · cited 1×
“The pathological process begins with the inhalation of an irritant (e.g., cold air) or an allergen (e.g., pollen), which then, due to bronchial hypersensitivity, leads to airway inflammation and to an increase in mucus production, creating an obstructive reversible bronchial condition [49,50].”
Background
Cited by
Update on the pathogenesis of atopic dermatitis.
Criado, P. R., Miot, H. A., Bueno-Filho, R., Ianhez, M., Criado, R. F. J., & de Castro, C. C. S. (2024) · Anais brasileiros de dermatologia · doi:10.1016/j.abd.2024.06.001 · Cited by 66
Personalized COPD Care: The Future of Precision-Based Therapies
Appleton, L. K., Hanania, N. A., & Adrish, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216339 · Cited by 18
“…rhinitis, atopic dermatitis, asthma, and nasal polyposis, suggesting that T2 inflammation is far more systemically pathologic beyond the lungs [24,25]. airway and other organ systems including allergic rhinitis, atopic dermatitis, asthma, and nasal polyposis, suggesting that T2 in fl ammation…”
BackgroundPace, G. M., Giombi, F., Pirola, F., Cerasuolo, M., Heffler, E. M., Paoletti, G., Puggioni, F., Mercante, G., Spriano, G., & Malvezzi, L. (2024) · Annals of Otology Rhinology & Laryngology · doi:10.1177/00034894241300812 · Cited by 12
Self-citationPiazzetta, G. L., Lobello, N., Pelaia, C., Preianò, M., Lombardo, N., & Chiarella, E. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2470477 · Cited by 10
“42 In this context, recent studies suggest that Korean Red Ginseng (Panax ginseng Meyer) may have potential benefits for improving ciliogenesis and ciliary function.”
Is Pollution the Primary Driver of Infectious Syndemics?
Singer, M. (2024) · Pathogens · doi:10.3390/pathogens13050370 · Cited by 8
Metadata
- Authors
- Giombi, F., Pace, G. M., Pirola, F., Cerasuolo, M., Ferreli, F., Mercante, G., Spriano, G., Canonica, G. W., Heffler, E., Ferri, S., Puggioni, F., Paoletti, G., & Malvezzi, L.
- Affiliations
- Humanitas University (IT)
- IRCCS Humanitas Research Hospital (IT)
- Corresponding author
- Pace, Gian Marco
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-01-05
- Volume
- 25
- Issue
- 2
- Pages
- 730
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10815382
- OpenAlex
- W4390617982
- Cited by
- 25
- References
- 139
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 6
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Keywords
- chronic rhinosinusitis, Th2 immune response, united airways, endotypes, atopic dermatitis, obstructive sleep apnea, nitric oxide, systemic inflammation, multi-organ disease
- MeSH terms
- Syndemic, Asthma, Humans, Respiration, Sleep Wake Disorders, Cytokines, Sleep Apnea, Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
